Topical Minoxidil: Review of Efficacy and Safety

Topical minoxidil, known as Rogaine, was approved by the FDA for treating androgenetic alopecia and had been approved in several other countries. The paper reviewed both anecdotal evidence and controlled clinical trials regarding its efficacy and safety. It highlighted the need for a realistic assessment of minoxidil's potential in restoring or preventing hair loss due to androgenetic alopecia.